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httpcense.Abstract Background: DOTS remains one of the most widely-implemented and longest-running
global health interventions in tuberculosis control.
Aim of the work: To evaluate DOTS strategy based on WHO guidelines on pulmonary tubercu-
losis in both Chest and Zagazig University Hospitals.
Patients and methods: This study was carried out at both Chest Department, Zagazig University
Hospitals and Zagazig Chest Hospital, in the period from October 2008 to October 2009. One hun-
dred and twenty patients with smear positive tuberculosis were included in this study. Group I: This
group included 60 patients; 48 (80%) of them were males and 12 (20%) were females. Their ages
ranged from 16 to 75 years old, with a mean age of 46.0 ± 11.1. Those patients were receiving anti-
tuberculous drugs according to DOTS guidelines suggested by the national tuberculosis control
program (NTP) in Egypt (2008) at the health facility nearest to their home. Group 2: Included
60 patients, they were 52 (86.7%) males and 8 (13.3%) females, their ages ranged from 20 to
70 years old with a mean age of 48 ± 12.3. Those patients were receiving self administration ther-
apy (SAT) by the same regimens as in Group I. All patients were subjected to; Medical history tak-
ing, Clinical examination, Routine laboratory investigation, Radiological examination, Sputum
analysis by Ziehl Neelsen stain for acid fast bacilli at the time of diagnosis, at the end of initial23595477.
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258 H. Elkomy et al.phase, at the end of the 5th month and at the end of the course.
Results: There were 38 patients (63.3%) cured in group I versus 20 (33.3%) in group II, with a
highly signiﬁcant difference between the two groups, as P< 0.005. There were 42 patients (70%)
regular in receiving the treatment in group I versus 24 (40%) in group II with a signiﬁcant difference
between the two groups as P< 0.05. There were 6 patients (10%) defaulters in group I versus 20
(33.3%) in group II, with a signiﬁcant difference between the two groups, as P< 0.05. There were
22 patients (36.7%) failed in the treatment in group I versus 40 (66.7%) in group II, with a highly
signiﬁcant difference between the two groups, as P< 0.005.
Conclusions: 1 – DOTS yields more cure rate in the treatment outcome of pulmonary tubercu-
losis and decreases the rate of failure and defaulting. 2 – Defaulting and non-adherence of the
patients could be considered as important factors for increased incidence of failure in the treatment
outcome of TB either under DOTS or SAT.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
DOTS remains one of the most widely-implemented and lon-
gest-running global health interventions. Given that DOTS
will likely continue to occupy a central place in global tubercu-
losis control efforts in coming years, the question of what
DOTS has or has not accomplished over the past 15 years is
a central technical question; it is also critical to global health
transparency and accountability. WHO has evaluated the per-
formance of DOTS in the course of speciﬁc studies as well as
detailed annual reports since 1997. These publications make
use of two major indicators of program performance: treat-
ment results and percent of tuberculosis cases detected by na-
tional programs [1–4].
Aim of the work
To evaluate DOTS strategy based on WHO guidelines on pul-
monary tuberculosis at both Zagazig chest hospital and chest
department of Zagazig university hospitals.
Patients and methods
This comparative study was carried out at both Chest Depart-
ment, Zagazig University Hospitals and Zagazig Chest Hospi-
tal, in the period from October 2008 to October 2009. One
hundred and twenty patients with smear positive tuberculosis
were included in this study. Patients were classiﬁed into two
groups during the study:
 Group I: This group included 60 patients with sputum +ve
pulmonary tuberculosis, 48 (80%) of them were males and
12 (20%) were females. Their ages ranged from 16 to
75 years old, with a mean age of 46.0 ± 11.1.
These patients were receiving antituberculous drugs accord-
ing to DOTS guidelines suggested by the national tuberculosis
control program (NTP) in Egypt (2008) at the nearest health
facility to their home. DOTS was administrated to all patients
by one of the following regimens:
 Regimen 1: All new cases with sputum smear +ve for acid
fast bacilli received six month treatment in the form of
2 month intensive phase; isoniazide, rifampicin, pyrazina-
mide and ethambutol, with daily direct observed treatmentthen 4 month continuation phase by isoniazide and rifampi-
cin with weekly receiving treatment from out patient clinics
as recommended in the national tuberculosis control pro-
gram (2008).If sputum smear still positive after the second
month, the initial phase was prolonged to another month
so the duration of intensive phase became 3 months.
 Regimen 2: It was given to patients with treatment failure or
treatment after interruption. These patients received eight
month treatment regimen in the form of 3 month intensive
phase by isoniazide, rifampicin, pyrazinamide and etham-
butol, with daily direct observed treatment then 5 month
maintenance phase by isoniazid, rifampicin and ethambutol
with weekly direct observed treatment.
 Group 2: Included 60 patients with smear +ve pulmonary
tuberculosis, they were 52 (86.7%) males and 8 (13.3%)
females, their ages ranged from 20 to 70 years old with a
mean age of 48 ± 12.3.These patients were receiving self
administration therapy (SAT) by the same regimens as in
Group I.
 All patients were subjected to the following:
(1) Medical history taking.
(2) Clinical examination including both general and local
examination.
(3) Routine laboratory investigation:¤ Complete blood picture.
¤ ESR.
¤ Fasting and post prandial blood glucose levels.
¤ Liver and kidney function tests.(4) Radiological examination:
¤ Plain chest X-ray PA and lateral views to all cases.
¤ Chest computed tomography (CT). It was done for
special cases (20 cases).(5) Sputum analysis: by Ziehl Neelsen stain for acid fast
bacilli.
(6) Follow up: It was done:(1). Clinically; as regards symptomatic improvement
and weight gain.
(2). Radiologically; by monthly plain chest X-ray.
(3). Laboratory; by repetition of blood picture, ESR,
liver and kidney functions.
(4). Sputum smear analysis by ZN stain as three sam-
ples were collected for smear examination at each
follow up visit according to (NTP 2008) guidelines
as the following.
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¤ At the end of initial phase.
¤ At the end of the 5th month.
¤ At the end of the course.The outcome of both groups at the end of treatment:
– Cured: If the patient has completed a full course of anti TB
therapy and there were two negative sputum smears for acid
fast bacilli by ZN stain during the continuation phase, one
of which at the end of treatment.
– Defaulter. If the patient interrupted treatment for any rea-
son more than two months.
– Failed: if the patient fails to achieve bacteriological conver-
sion within 5 months after start of treatment or after previ-
ous conversion becomes sputum smear positive again.
Statistical analysis
Data were tabulated and statistically analyzed using Epi-
IWFO (2005) and SPSS version-IO software package.haracteristics of patients in both groups.
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to 47 patients (78.3%) not under DOTS and at the end of the
ts (66.6%) not under DOTS.Results
See Tables 1–5.
Discussion
Tuberculosis remains a major global health problem. Consid-
erable debate has arisen about DOTS place in the future of
global tuberculosis control efforts [5].
Lopez et al. [6] studied the effect of DOTS using time-series
cross-sectional methods. They ﬁrst estimated the impact of
DOTS expansion on case detection. Then they estimated the
effect of DOTS expansion on treatment success. DOTS pro-
gram variables had no statistically signiﬁcant impact on case
detection in a wide range of models and speciﬁcations. DOTS
population coverage had a signiﬁcant effect on overall treat-
ment success rates, such that countries with full DOTS cover-
age beneﬁt from at least 18% increase in treatment success.
In our study, there were 42 patients (70%) regular in the
treatment in group I versus 24 (40%) in group II, with a signif-
icant difference between the two groups (Table 1).This was in
agreement with Ashry et al. [7], who reported that the regular-
ity in receiving treatment is better in DOTS group. The reasons
for poor adherence are multifaceted and complex, but includeGroup II (60) X2 P
No %
4 6.7 2.91 >0.05
56 93.3
24 40.0
36 60.0 10.9 <0.05
20 33.3 9.62 <0.005
40 66.7 10.81 <0.005
20 33.3
I versus 4 (6.7%) in group II and this difference is not signiﬁcant as
s 24 (40%) in group II with a signiﬁcant difference between the two
3%) in group II, with a signiﬁcant difference between the two groups,
s 40 (66.7%) in group II, with a highly signiﬁcant difference between
.3%) in group II, with a highly signiﬁcant difference between the two
h groups.
roup II (60) X2 P
o %
0 100 Not computed
7 78.3
3 71.6 4.44 <0.05
0 66.6 6.4 <0.05
t 2nd and 5th m) and at the end of the treatment in both groups: all
t the end of 2nd m, 35 patients (58.3%) under DOTS were positive
treatment 22 patients (36.6%) under DOTS were positive comparable
Table 3 Characteristics of the patients with treatment failure in both groups.
Group I (n= 22) Group II (n= 40) P
No % No %
Age (16–70)
42.1 ± 15
(14–72)
43.0 ± 13
t-test 0.91 >0.05
Sex
Male 16 72.7 38 95 Fisher >0.05
Female 6 27.3 2 5
Educated 0 0.0 4 10.0 Fisher >0.05
Not educated 22 100.0 36 90.0
Cig. smoking 12 54.5 13 32.5 2.87 >0.05
Goza smoking 10 45.5 27 67.5
Regular on treatment 4 18.1 4 10.0 Fisher >0.05
Irregular on treatment 18 81.9 36 90.0
Defaulters 4 18.1 20 50 >0.05
¤ The table shows that there is a non-signiﬁcant difference between the two groups regarding age, sex, education, smoking, and regularity in
treatment as P> 0.05.
Table 4 Statistical comparison between cured and failed cases under DOTS (Group I).
Failed cases (n= 22) Cured cases (n= 38) Test P
No % No %
Educated 0 0.0 10 26.3 Fisher <0.05
Not educated 22 100 28 73.7
Cig smokers 12 54.5 18 47.3 X2 >0.05
Goza smokers 10 45.5 20 52.7 0.29
Regular 4 18.1 38 100.0 X2 <0.001
Irregular 18 81.9 0 0.0 44.4
Defaulters 4 18.1 2 5.2 Fisher >0.05
¤ There is a signiﬁcant difference between the failed and cured cases in group I regarding education as P< 0.05 and there is a very high
signiﬁcant difference regarding regularity as P< 0.001.
Table 5 Statistical comparison between cured and failed cases not under DOTS (Group II).
Failed cases (n= 40) Cured cases (n= 20) Test P
No % No %
Educated 4 10.0 0.0 0.0 Fisher >0.05
Not educated 36 90 20 100
Cig smokers 13 32.5 9 45 X2 >0.05
Goza smokers 27 67.5 11 55.5 0.9
Regular 4 10 20 100 X2 <0.001
Irregular 36 90 0 0.0 45
Defaulters 20 50 0 0.0 X2
15
<0.001
¤ The table shows that there is a non-signiﬁcant difference between the failed and cured cases in group II regarding
education and smoking as P> 0.05 and there is a very high signiﬁcant difference regarding compliance and defaulters
as P< 0.001.
260 H. Elkomy et al.the characteristics of the individual patient, social and eco-
nomic factors such as the availability of drugs, communication
between the patient and health care providers, duration and
number of medications needed, side effects and cost of treat-
ment. Also the same result was reported by Sumartoyo [8],
in China who revealed that TB treatment was completed by73.1% of patients within 9 months under DOTS while 28.9%
failed to complete their regimen.
Pandit and Choudhary [9] study showed that 93% of the
studied population was regular in receiving DOTS. However
the study done by Tekle et al. [10] found that 11.3% of all stud-
ied population in Ethiopia in 1997–99 was irregular.
Assessment of the efﬁcacy of directly observed treatment with short course (DOTS) 261The main risk factors for irregularity were studied by Ashry
et al. [7] and Boyle et al. [4], as the role of health education,
toxicity of drugs, cost of investigation and therapy, timing of
therapy, travel for therapy, long waiting period for treatment
and role of DOTS provider. Out of the previous factors, the
health education had the major effect for non-compliance.
This study revealed that the compliance of DOTS was signiﬁ-
cantly high among those who have good knowledge about var-
ious aspects of the disease.
As regards the defaulting, there were 6 patients (10%)
defaulters in group I and 20 patients (33.3%) in group II, (Ta-
ble 1) and the difference was very highly signiﬁcant between
the two groups. This was in agreement with Elmahalli and Ab-
del-Aziz [11] who reported that defaulter rate increases in SAT
(Self-Administrated Therapy) due to lack of supervision and to
the feeling of improvement or cure, so stopping drugs very
early. As well as they mentioned that defaulting is the most
common cause of multidrug resistance which is considered
the most important difﬁculty in treatment and control of infec-
tion. As regards treatment failure (Table 1) showed that, there
were 22 patients (36.7%) failed in group I versus 40 patients
(66.7%) in group II, with a statistical signiﬁcant difference be-
tween the two groups. The predictors of treatment failure re-
ported in this study were:
1. Non-compliance to treatment,
2. Deﬁcient patient knowledge/health education.
This result is in agreement with Morsy et al. [12] who re-
ported that the possible signiﬁcant risk factors for treatment
failure were:
1. Deﬁcient health education sessions to the patient (more
than 11-fold increased risk for treatment failure).
2. Poor patient knowledge regarding the disease (almost 5-
fold increased risk for treatment failure).
3. Missed doses of antituberculous drugs (1.4-fold increased
risk for each dose missed).
Other possible factors could be drug resistance or drug
quality, which were not investigated in this study. Non-compli-
ance is a behavioral problem, the determinants of which vary
from one context to another. It has always been associated
with the emergence of multidrug- resistant TB and poor treat-
ment outcome [13,14].
As regards the comparison between cured and failed cases
in group I under DOTS (Table 4): There was a signiﬁcant dif-
ference between them regarding education and compliance
.This was in agreement with a study of Morsy et al. [12] who
mentioned that non-compliance is a behavioral problem. It
has always been associated with the emergence of multidrug-
resistant TB and poor treatment outcome. In a study in Nige-
ria, the only factor that signiﬁcantly inﬂuenced the rate of
compliance was proximity to the chest clinic [15]. On the other
hand, in agreement with our results, the extent of health edu-
cation and patient knowledge regarding the disease have beenshown to be signiﬁcant determinants of adherence to treat-
ment, and consequently, of treatment failure.In conclusions 1
– DOTS yields more cure rate in the treatment outcome of pul-
monary tuberculosis and decreases the rate of failure and
defaulting. 2 – Defaulting and non-adherence of the patients
could be considered as important factors for increased inci-
dence of failure in the treatment outcome of TB either under
DOTS or SAT.
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